| 2.1 |
POLICIES GOVERNING THE PROVISION OF SERVICES |
| 2.1 A |
POLICIES ON THE PRONOUNCEMENT OF DEALTH BY A REGISTERED NURSE (TEXAS ONLY) |
| 2.2 |
SERVICES PROVIDED |
| 2.2A |
RESEARCH PARTICIPATION |
| 2.3 |
ON-CALL POLICY |
| 2.4 |
SERVICE POLICIES NURSING SERVICE |
| 2.5 |
GUIDELINES FOR ASSESSMENT |
| 2.6 |
CARE PLAN |
| 2.7 |
SERVICE POLICIES - OTHER HEALTH CARE PROFESSIONAL SERVICES |
| 2.7A |
SUBMISSION OF CLINICAL RECORDS VISIT |
| 2.8 |
DELEGATION OF TASKS TO UNLICENSED PERSONNEL |
| 2.9 |
REFERAL AND ACCEPTANCE OF PATIENTS / CLIENTS |
| 2.10 |
CASE MANAGEMENT AND ASSIGNMENTS |
| 2.11 |
STAFFING PLAN |
| 2.12 |
SERVICES UNDER CONTRACT |
| 2.13 |
ELIGIBILITY CRITERIA |
| 2.14 |
DISCHARGE/TRANSFER POLICY |
| 2.15 |
FIELD SAFETY MEASURES |
| 2.16 |
NON COVERED SERVICES |
| 2.17 |
MEDICAL RELATIONSHIP POLICIES |
| 2.18 |
PHYSICIAN'S PLAN OF TREATMENT |
| 2.18A |
PHYSICIAN'S FACE-TO-FACE ENCOUNTER |
| 2.19 |
ORDERS FROM OTHER THAN A MEDICAL DOCTOR |
| 2.20 |
PHYSICIAN RESPONSIBILITIES |
| 2.21 |
CASE PRIORITIZING GUIDELINES |
| 2.22 |
PATIENT/CLIENT INVOLVEMENT IN CARE PLANNING |
| 2.23 |
PATIENT/CLIENT NOTIFICATION OF CHANGES |
| 2.24 |
CONSENT PRACTICES |
| 2.25 |
REFUSAL OF CARE |
| 2.26 |
PATIENT CARE GUIDELINES |
| 2.27 |
CONTINGENCY PLAN |
| 2.28 |
GENERAL MEDICAL CARE POLICIES |
| 2.28A |
VACCINATIONS |
| 2.29 |
WOUND PHOTOGRAPHY |
| 2.30 |
COORDINATION OF SERVICES |
| 2.31 |
CASE CONFERENCES |
| 2.32 |
SAFETY‐PATIENT / CLIENT SETTING |
| 2.33 |
HOME SAFETY GUIDELINES |
| 2.34 |
HOME SAFETY ASSESSMENT |
| 2.35 |
PRIVACY, SECURITY, AND RESPECT OF PROPERTY |
| 2.36 |
COMMUNICATION BARRIERS AND CULTURAL
CONSIDERATIONS |
| 2.37 |
CLINICAL RECORD CONTENTS |
| 2.38 |
COPYING THE CLINICAL RECORD |
| 2.39 |
FACSIMILE AND CELLULAR TRANSMISSIONS |
| 2.40 |
OUTCOME AND ASSESSMENT INFORMATION SET (OASIS) |
| 2.40A |
FORMS AND DEVELOPMENT |
| 2.41 |
USE OF APPROVED ABBREVIATIONS AND SYMBOLS |
| 2.42 |
CLINICAL RECORD DESTRUCTION / DISPOSAL |
| 2.43 |
INTERAGENCY COMMUNICATION |
| 2.44 |
SKILLS COMPETENCY |
| 2.45 |
SUPERVISION AND EVALUATION OF STAFF |
| 2.46 |
STAFF EDUCATION POLICY |
| 2.46A |
CONTINUING EDUCATION REQUIREMENTS FOR ADMINISTRATOR / ALTERNATE ADMINISTRATOR (TEXAS ONLY) |
| 2.47 |
PATIENT/CLIENT EDUCATION |
| 2.48 |
HOME HEALTH AIDE SERVICE |
| 2.49 |
HOME HEALTH AIDE SUPERVISORY VISITS |
| 2.50 |
GUIDELINES FOR AIDE PERFORMANCE EVALUATIONS |
| 2.51 |
MEDICATION ADMINISTRATION |
| 2.52 |
POSSESSION OF STERILE WATER OR SALINE CERTAIN VACCINES OR TUBERCULIN
AND CERTAIN DANGEROUS DRUGS |
| 2.53 |
MEDICATION PROFILE |
| 2.54 |
ADMINISTRATION OF MEDICATION |
| 2.55 |
LABELING AND STORAGE OF MEDICATION |
| 2.56 |
DRUGS APPROVED FOR ADMINISTRATION |
| 2.57 |
MEDICATION ADMINISTRATION GUIDELINES |
| 2.58 |
MEDICATION REFRIGERATOR |
| 2.59 |
MEDICATION ERRORS |
| 2.60 |
ADVERSE MEDICATION REACTION |
| 2.61 |
CONTROLLED SUBSTANCES |
| 2.62 |
CONSENT FOR ADMINISTRATION OF POTENTIALLY DANGEROUS OR EXPERIMENTAL
DRUG |
| 2.63 |
SUICIDE POLICY |
| 2.64 |
EXPIRATION POLICY |
| 2.65 |
CARE OF THE DYING PATIENT / CLIENT |
| 2.66 |
EMERGENCY RESUSCITATION |
| 2.67 |
CLIA CERTIFICATE OF WAIVER FOR GLUCOMETER TESTING |
| 2.68 |
POLICY FOR WHOLE BLOOD GLUCOSE MONITORING POLICY UNDER CLIA
WAIVER |
| 2.69 |
OBTAINING AND TRANSPORTING LABORATORY SPECIMENS |
| 2.69A |
PROTHROMBIN TIME TESTING IN THE HOME |
| 2.70 |
MECHANICAL VENTILATOR PATIENTS / CLIENTS |
| 2.71 |
OTHER TREATMENTS AND TECHNIQUES |
| 2.72 |
STANDING ORDERS |
| 2.73 |
TELEMEDICINE |
| 2.74 |
USE OF RESTRAINTS |
| 2.74A |
CHEST RESTRAINT PROCEDURES |
| 2.75 |
ETHICAL ISSUES |
| 2.76 |
ABUSE, NEGLECT AND EXPLOITATION |
| 2.77 |
PATIENT / CLIENT SATISFACTION SURVEY |
| 2.77A |
PATIENT SATISFACTION FOR AGENCIES ADMITTING OVER 60 PATIENTS IN ONE YEAR |
| 2.78 |
BAG TECHNIQUE |
| 2.79 |
HAND WASHING POLICY |
| 2.80 |
EQUIPMENT MANAGEMENT SERVICES |
| 2.81 |
CARE OF REUSABLE AND DISPOSABLE EQUIPMENT |
| 2.82 |
ADVERSE EVENTS / INCIDENTS AND UNUSUAL OCCURRENCES |
| 2.83 |
DO NOT RESUSCITATE (DNR) |
| 2.84 |
FOREGOING LIVE SUSTAINING MEASURES |
| 2.85 |
ADVANCE DIRECTIVES |
| 2.86 |
MEDICARE/MEDICAID REQUIREMENTS FOR ADVANCE DIRECTIVES |
|
|